UNSPSC 51281907: Rufocromomycin or streptonigrin

This classification denotes an antineoplastic antibiotic with the molecular structure C25H22N4O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 261Q3JB310 chemically known as 2-pyridinecarboxylic acid, 5-amino-6-(7-amino-5,8-dihydro-6-methoxy-5,8-dioxo-2-quinolinyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methyl- but generally known as rufocromomycin, which bears US NIH Compound Identifier 5323583.

UNSPSC 51281907 Rufocromomycin or streptonigrin is a Commodity code covering specialized pharmaceutical compounds used in research and medical applications. State and local government procurement under this code is minimal; the source contains no recent opportunities and no evidence of routine purchasing activity by state agencies, counties, cities, school districts, transit authorities, or other state or local bodies. This code does not appear to reflect active state or local procurement at this time.

No representative recent opportunities are available to assess issuing-body mix, geographic spread, or market activity. Business development professionals evaluating pursuit under this code should verify whether state or local customers have procurement need for these specific compounds before investing in response infrastructure or compliance preparation.